1. Home
  2. BNTC vs ELTK Comparison

BNTC vs ELTK Comparison

Compare BNTC & ELTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • ELTK
  • Stock Information
  • Founded
  • BNTC 1995
  • ELTK 1970
  • Country
  • BNTC United States
  • ELTK Israel
  • Employees
  • BNTC N/A
  • ELTK N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • ELTK Electrical Products
  • Sector
  • BNTC Health Care
  • ELTK Technology
  • Exchange
  • BNTC Nasdaq
  • ELTK Nasdaq
  • Market Cap
  • BNTC 88.1M
  • ELTK 73.9M
  • IPO Year
  • BNTC N/A
  • ELTK 1997
  • Fundamental
  • Price
  • BNTC $11.82
  • ELTK $10.87
  • Analyst Decision
  • BNTC Buy
  • ELTK
  • Analyst Count
  • BNTC 6
  • ELTK 0
  • Target Price
  • BNTC $23.83
  • ELTK N/A
  • AVG Volume (30 Days)
  • BNTC 52.1K
  • ELTK 29.7K
  • Earning Date
  • BNTC 02-11-2025
  • ELTK 11-19-2024
  • Dividend Yield
  • BNTC N/A
  • ELTK 2.00%
  • EPS Growth
  • BNTC N/A
  • ELTK N/A
  • EPS
  • BNTC N/A
  • ELTK 0.85
  • Revenue
  • BNTC N/A
  • ELTK $48,090,000.00
  • Revenue This Year
  • BNTC N/A
  • ELTK $7.47
  • Revenue Next Year
  • BNTC N/A
  • ELTK $9.96
  • P/E Ratio
  • BNTC N/A
  • ELTK $12.94
  • Revenue Growth
  • BNTC N/A
  • ELTK 7.22
  • 52 Week Low
  • BNTC $2.69
  • ELTK $9.00
  • 52 Week High
  • BNTC $13.29
  • ELTK $22.80
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 62.51
  • ELTK 47.80
  • Support Level
  • BNTC $11.36
  • ELTK $10.51
  • Resistance Level
  • BNTC $13.29
  • ELTK $11.17
  • Average True Range (ATR)
  • BNTC 0.96
  • ELTK 0.55
  • MACD
  • BNTC 0.23
  • ELTK -0.02
  • Stochastic Oscillator
  • BNTC 86.05
  • ELTK 45.85

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.

About ELTK Eltek Ltd.

Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnects. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.

Share on Social Networks: